Impact of serial measurements of lysophosphatidylcholine on 28-day mortality prediction in patients admitted to the intensive care unit with severe sepsis or septic shock
Authors:
- 1 October 2014
- journal article
- research article
- Published by Elsevier in Journal of Critical Care
- Vol. 29 (5) , 882.e5-882.e11
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Influence of Systemic Inflammatory Response Syndrome and Sepsis on Outcome of Critically Ill Infected PatientsAmerican Journal of Respiratory and Critical Care Medicine, 2003
- The Pathophysiology and Treatment of SepsisNew England Journal of Medicine, 2003
- Lysophosphatidylcholine as a ligand for immunoregulationBiochemical Pharmacology, 2002
- Lysophosphatidylcholine as a Ligand for the Immunoregulatory Receptor G2AScience, 2001
- Mice Lacking the Orphan G Protein-Coupled Receptor G2A Develop a Late-Onset Autoimmune SyndromeImmunity, 2001
- Cytokine Dysregulation Induced by Apoptotic Cells Is a Shared Characteristic of Murine LupusThe Journal of Immunology, 2000
- AtherosclerosisNature, 2000
- Lipid mediators in the pathophysiology of critical illnessCritical Care Medicine, 2000
- Lysophosphatidylcholine transcriptionally induces growth factor gene expression in cultured human endothelial cells.Journal of Clinical Investigation, 1994
- Oxidatively modified low density lipoprotein is a chemoattractant for human T lymphocytes.Journal of Clinical Investigation, 1993